W.G. Shaheen & Associates DBA Whitney & Co
Position in BBIO — BridgeBio Pharma, Inc.
CIK 1577001
ROCHESTER, NY
Position in BBIO
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$376,124
+$1,111 QoQ
Shares Held
5,050
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#295
of 469 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Dec 31, 2025CallValue
$688,410
CallShares
9,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026W.G. Shaheen & Associates DBA Whitney & Co holds $22,864,032 across 3 Biotechnology names. BBIO ranks #2 (1.6% of the industry book) .
All Filings in BBIO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $376,124 | 5,050 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $375,013 | 5,050 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $688,410 | 9,000 | Call | Sole | 2026-01-30 | |
| 2025-12-31 | $256,241 | 3,350 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $623,280 | 12,000 | Call | Sole | 2025-11-07 | |
| 2025-09-30 | $389,550 | 7,500 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $518,160 | 12,000 | Call | Sole | 2025-08-05 | |
| 2025-06-30 | $392,938 | 9,100 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $295,573 | 8,550 | Shares | Sole | 2025-05-06 | |
| 2025-03-31 | $414,840 | 12,000 | Call | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||